Attitudes Toward Proactive Topical Corticosteroid Use Among Women With Vulval Lichen Sclerosus.
J Low Genit Tract Dis
; 28(2): 183-188, 2024 Apr 01.
Article
em En
| MEDLINE
| ID: mdl-38518216
ABSTRACT
OBJECTIVES:
Some practitioners are adopting proactive topical corticosteroid (TCS) therapy for vulval lichen sclerosus (VLS). We sought to understand patient attitudes toward proactive TCS therapy for VLS in a context in which proactive therapy is adopted.METHODS:
Four online focus group discussions with 12 participants. Data analysis was informed by social constructionist grounded theory.RESULTS:
All participants had accepted a proactive regimen. Three themes were developed from theanalysis:
"Coming to accept proactive therapy," "Motivators to maintaining a proactive regimen," and "The importance of a routine that fits me." Within each theme are subthemes illustrating different dimensions of the theme.CONCLUSIONS:
Accepting proactive TCS therapy for VLS requires incorporating regular TCS use into a patient's identity, unlearning previous understandings regarding the safety of long-term TCS use, and adopting a regimen that fits within patients' lives and minimizes the loss of autonomy.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Líquen Escleroso e Atrófico
/
Fármacos Dermatológicos
/
Líquen Escleroso Vulvar
Limite:
Female
/
Humans
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article